The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (1 analysts) rates it strong buy, with a mean price target of $26.
NexGen Energy Ltd. NXE
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, evaluation, and development of uranium properties in Canada.
read at $10.23
NexGen Energy Ltd. holds its Accumulation at $10.23.
- PHPhase · the trend structure carries the Accumulation label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · screen not yet scored
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 8 days |
| Price | $10.23 |
| Valuation | N/A trailing · -55.02 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | N/A |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Profit margin | 0.00% |
| Debt to equity | 33.24 |
| Analyst consensus | Strong Buy · 1 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This security has not been fully scored against the values screen yet.
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 23.7% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 13.0% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 32.5% of assets, under the 49% limit. Pass
- Revenue purity of revenue comes from non-compliant sources, over the 5% line. Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Uranium Explorer Offers No Clear Path Forward
Picture a miner still mapping the rock face while the world argues over nuclear fuel. NexGen sits in that exact spot, an exploration outfit with one key Canadian project but zero revenue and a negative forward earnings multiple that signals deepening losses rather than any bargain.
We pass outright. The business posts a zero profit margin and negative thirty percent return on equity, while the ethical screen returns insufficient data because basic financial ratios are missing. In a cyclical uranium market, low or negative multiples often mark peak hope rather than value, and here the opportunity rating confirms none exists.
High execution risk remains the real story, with development timelines, permitting and commodity swings all still ahead. One bullish analyst target does not change the absence of a working operation. Analysis, not advice.
| Forward P/E | -55.0x |
| Profit margin | 0.0% currently unprofitable |
| Return on equity | -17.7% not currently earning a positive return on equity |
| Debt to equity | 0.33 minimal debt — a conservative balance sheet |
| Current ratio | 1.46 adequate liquidity, worth monitoring |
| Market cap | $6.9B |
| Employees | 142 |
The risks · The things to watch: its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in NXE's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
NXE trades on the NYSE (the company is based in Canada). As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 11% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 46%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (1 analysts) rates it strong buy, with a mean price target of $26.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $12.66 | -26.7% | · | $733 | -26.7% |
| 2 months | $11.39 | -18.5% | · | $815 | -18.5% |
| 3 months | $12.46 | -25.5% | · | $745 | -25.5% |
| 6 months | $9.43 | -1.6% | · | $984 | -1.6% |
| 1 year | $6.36 | +45.9% | · | $1,459 | +45.9% |
| 2 years | $7.04 | +31.8% | · | $1,318 | +31.8% |
| 3 years | $4.39 | +111.4% | · | $2,114 | +111.4% |
| 5 years | $4.87 | +90.6% | · | $1,906 | +90.6% |
Historical returns from market close data. Past performance does not guarantee future results.